Search
for
Sort by
Research 31–60 of 1000+
- Prostate cancer risk and recurrence: the role of nutrition and clinical aspects
- Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells
- Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy
- A Slippery Preventive Slope
- Abstract ED05-04: Presurgical models to effectively screen preventive agents
- Male alopecia, finasteride, and cancer risk
- Editorial comment 1
- PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice
- Finasteride
- Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model
- Level-1 Data From the REDUCE Study and the PCPT Data
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Clinical Pearls in Men's Health
- Provenge is Talk of GU Malignancies Congress
- C-2-3 GND-VIAを用いたX帯SiGe-MMIC増幅器(C-2. マイクロ波A(能動デバイス), エレクトロニクス1)
- Editorial comment
- Proscar and Propecia—A Therapeutic Perspective
- Abstract SS02-02: Chemoprevention: Poised for Success
- Finasteride chemoprevention might be cost-effective in high-risk populations
- Side effects of androgen deprivation therapy: monitoring and minimizing toxicity
- The <i>BJUI</i>'s clinical trials initiative
- Editorial Comment
- Editorial Comment
- L'etude PCPT : regards d'un urologue intéressé
- Finasteride en el año 2006
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- Reply
- Finasteride Doesn't Shorten Survival in Long-term Study
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond